Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus

Clinical trial NCT05188521 · COMPLETED

Trial details

NCT number: NCT05188521
Sponsor: Aaron R. Mangold
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Lichen Planus

Start date: 2022-01-11
Primary completion: 2023-05-17
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.